[1
]The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group
[2
]Guy’s and St Thomas’ NHS Foundation Trust, ICU Support Offices, St Thomas’ Hospital,
London, England
[3
]School of Immunology and Microbial Sciences, Kings College London, London, England
[4
]University College London, MRC Clinical Trials Unit at UCL, London, England
[5
]Population Health Sciences, Bristol Medical School, University of Bristol, Bristol,
England
[6
]NIHR Bristol Biomedical Research Centre, Bristol, England
[7
]National Institute for Health Research Applied Research Collaboration West at University
Hospitals Bristol and Weston NHS Foundation Trust, Bristol, England
[8
]University of Bristol, Bristol, England
[9
]Assistance Publique–Hôpitaux de Paris, Centre for Clinical Epidemiology, Hôpital Hôtel-Dieu,
Paris, France
[10
]INSERM UMRS-1153, Centre de Recherche Epidémiologie et Statistique Université de Paris,
METHODS Team, Paris, France
[11
]Department of Nursing, Hadassah Hebrew University Medical Center, Jerusalem, Israel
[12
]Berry Consultants, Austin, Texas
[13
]Turku University Hospital, Department of Infectious Diseases, Turku, Finland
[14
]BP-A Beneficência Portuguesa de São Paulo, Rua Maestro Cardim, São Paulo, Brazil
[15
]Department of Public Health and Primary Care, Ghent University, Ghent, Belgium
[16
]Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht,
the Netherlands
[17
]Department of Infectious Diseases, Hospital de la Santa Creu i Sant Pau, Barcelona,
Spain
[18
]Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia
[19
]Infectious Diseases Unit, Internal Medicine Department, Hospital Universitario Puerta
de Hierro-Majadahonda, Madrid, Spain
[20
]Department of Pulmonary Diseases, Turku University Hospital, Turku, Finland
[21
]Infectious Diseases Department, Hospital Clinic Barcelona-IDIBAPS, Barcelona, Spain
[22
]Rheumatology, Hospital Universitario La Princesa IIS-IP, Madrid, Spain
[23
]Division of Anaesthetics, Pain Medicine and Intensive Care, Imperial College London,
London, England
[24
]Nuffield Department of Population Health, University of Oxford, Oxford, England
[25
]MRC Population Health Research Unit, University of Oxford, Oxford, England
[26
]Department of Hematology, Necker Hospital, Paris, France
[27
]Imagine Institute, University of Paris, INSERM U1153, Paris, France
[28
]Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University
of Oxford, Oxford, England
[29
]International Severe Acute Respiratory and Emerging Infections Consortium, University
of Oxford, Oxford, England
[30
]Pandemic Sciences Centre, University of Oxford, Oxford, England
[31
]Department of Medicine, Massachusetts General Hospital, Boston
[32
]Medanta-The Medicity, Institute of Liver Transplantation and Regenerative Medicine,
Gurugram, India
[33
]Research Department, Medanta Institute of Education and Research, Gurugram, India
[34
]VIB Center for Inflammation Research, Ghent University, Ghent, Belgium
[35
]Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium
[36
]Regeneron Pharmaceuticals Inc, Tarrytown, New York
[37
]Centre for Immunology of Viral Infections and Autoimmune Diseases, Université Paris-Saclay,
INSERM UMR1184, Le Kremlin-Bicêtre, Paris, France
[38
]Department of Rheumatology, Assistance Publique–Hôpitaux de Paris, Le Le Kremlin-Bicêtre,
Paris, France
[39
]Unit of Infectious Diseases and Microbiology, Valme University Hospital, Institute
of Biomedicine of Sevilla, Seville, Spain
[40
]Hospital Sungai Buloh, Ministry of Health, Buloh, Malaysia
[41
]Genentech, South San Francisco, California
[42
]Hospital Universitario Ramón y Cajal IRYCIS, Infectious Diseases Department, Madrid,
Spain
[43
]Department of Anesthesilogy Critical Care and Pain Medicine, Hadassah Hebrew University
Hospital, Jerusalem, Israel
[44
]University de Paris, CRESS UMR1153, INSERM, INRA, Paris, France
[45
]Department of Rheumatology and Clinical Immunology, University Hospital Groningen,
University Medical Center Groningen, Groningen, the Netherlands
[46
]Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne,
Australia
[47
]Department of Paediatric Rheumatology, University Hospitals Bristol, NHS Foundation
Trust, Bristol, England
[48
]Department of Medicine (Rheumatology), University of Chicago Medical Center, Chicago,
Illinois
[49
]Department of Clinical Pharmacology, Hospital Universitario Puerta de Hierro Majadahonda,
Madrid, Spain
[50
]Center for Outcomes Research and Evaluation, Queen’s Medical Center, Honolulu, Hawaii
[51
]Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital,
Boston
[52
]Department of Medicine (Rheumatology), Massachusetts General Hospital, Boston
[53
]VA Ann Arbor, Center for Clinical Management and Research, Ann Arbor, Michigan
[54
]Department of Infectious Diseases, Karolinska Institute at Karolinska University Hospital
Huddinge, Stockholm, Sweden
[55
]Maimonides Institute for Biomedical Research of Cordoba/Reina Sofia University Hospital/University
of Córdoba, Córdoba, Spain
[56
]Global Medical Affairs, Sanofi-Genzyme, Bridgewater, New Jersey
[57
]Department of Hematology, University Medical Center Groningen, Groningen, the Netherlands
[58
]Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, the Netherlands
[59
]Department of Pediatrics, University of British Columbia, Vancouver, Canada
[60
]Clinical Unit, Health Emergencies Programme, World Health Organization, Geneva, Switzerland
[61
]Li Ka Shing Knowledge Institute, St Michael’s Hospital, University of Toronto, Toronto,
Ontario, Canada
[62
]Health Data Research UK South-West, Bristol, England